9 completed, 3 recruiting, 2 not yet recruiting, 2 unknown. 2 Not applicable, 2 Phase 1, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 2 | Completed 2 |
Follow Arthritis, Reactive: new trials by email Literature Review of Arthritis, Reactive trials Research Report on Arthritis, Reactive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases Rheumatoid Arthritis (RA, Ankylosing Spondylitis | Not yet recruiting | Bursa City Hospital | 300 | 2026-01-15 | 2026-01-09 | |
| Pain in Inflammatory Joint Diseases Biological or targeted synthetic DMARD - Arthritis, Arthritis, Juvenile Idiopathic | Recruiting | Diakonhjemmet Hospital | 350 | 2025-11-11 | 2026-04-13 | |
| Chinese Spondyloarthritis Inception Cohort (CESPIC) Celecoxib - Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA), Non-radiographic Axial Spondyloarthritis (Nr-axSpA) | Not yet recruiting | Southwest Hospital, China | 1000 | 2024-09-01 | 2024-04-17 | |
| Monitoring of Inflammatory Conditions Questionnaire, Semi-structured interview - Inflammatory Disease, Crohn Disease | Completed | University of Nottingham | 664 | 2022-06-28 | 2024-02-28 | |
| Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors Best Practice, Educational Intervention, Interview - Ankylosing Spondylitis, Autoimmune Disease | Recruiting | M.D. Anderson Cancer Center | 125 | 2022-04-20 | 2026-05-20 | |
| Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 Semi-structured qualitative interview - Inflammatory Disease, Rheumatoid Arthritis | Completed | University of Nottingham | 20 | 2021-11-01 | 2022-04-15 | |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis | Phase 1 / Phase 2 | Unknown | All Natural Medicine Clinic, LLC | 2000 | 2021-03-01 | 2021-05-26 |
| Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults ShigETEC live, attenuated, oral vaccine, Placebo - Diarrheal Disease, Infectious, Gastrointestinal Disease | Phase 1 | Completed | Eveliqure Biotechnologies GmbH | 84 | 2020-09-16 | 2022-06-08 |
| Rheumatology Patient Registry and Biorepository Rheumatic Diseases, Adult Onset Still Disease | Recruiting | Yale University | 5000 | 2020-08-04 | 2026-02-13 | |
| Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD Rifaximin, Placebo - Travelers' Diarrhea, Functional Bowel Disorders | Not applicable | Completed | Henry M. Jackson Foundation for the Advancement of Military Medicine | 449 | 2015-11-10 | 2023-02-15 |
| Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis Secukinumab - Spondylarthropathies | Phase 3 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 20 | 2014-03-01 | 2017-11-30 |
| Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria Doxycycline and Rifampin, Azithromycin and Rifampin, Placebo - Arthritis, Reactive, Reiter Disease | Phase 3 | Completed | University of South Florida | 42 | 2006-05-01 | 2018-11-13 |
| New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis interferon-gamma, infliximab, dmard - Reactive Arthritis | Phase 2 | Unknown | Charite University, Berlin, Germany | 40 | 2003-01-01 | 2006-09-08 |
| Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients Arthritis, Reactive, Arthritis, Rheumatoid | Completed | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 250 | 1998-08-01 | 2008-03-04 | |
| The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis Arthritis, Arthritis, Reactive | Completed | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 500 | 1994-08-01 | 2008-03-04 | |
| Study of Long-Term Antibiotic Treatment in Reactive Arthritis ofloxacin and roxithromycin, placebo - Reactive Arthritis | Not applicable | Completed | University of Helsinki | 56 | 1993-11-01 | 2008-02-22 |
Arthritis, Rheumatoid (8) · Arthritis, Psoriatic (7) · Spondylitis, Ankylosing (5) · Lupus Erythematosus, Systemic (4) · Arthritis (3) · Colitis, Ulcerative (3) · Crohn Disease (3) · Infections (2) · Inflammatory Bowel Diseases (2) · Psoriasis (2) · Synovitis (2) · Ageusia (1) · Anosmia (1) · Antiphospholipid Syndrome (1)
Arthritis, Infectious (16) · Bone Diseases (16) · Chronic Disease (16) · Disease Attributes (16) · Joint Diseases (16) · Musculoskeletal Diseases (16) · Pathologic Processes (16) · Pathological Conditions, Signs and Symptoms (16) · Spinal Diseases (16) · Spondylitis (16) · Post-Infectious Disorders (15) · Spondylarthritis (15) · Spondylarthropathies (15) · Infections (14) · Arthritis (13)
Antirheumatic Agents (1) · Azithromycin (1) · Biological Products (1) · Celecoxib (1) · Doxycycline (1) · Early Intervention, Educational (1) · Educational Status (1) · Infliximab (1) · Interferon-gamma (1) · Interviews as Topic (1) · Methods (1) · Ofloxacin (1) · Placebo Effect (1) · Practice Guidelines as Topic (1) · Rifampin (1)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2) · University of Nottingham (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · All Natural Medicine Clinic, LLC (1) · Bursa City Hospital (1) · Charite University, Berlin, Germany (1) · Diakonhjemmet Hospital (1) · Eveliqure Biotechnologies GmbH (1) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · M.D. Anderson Cancer Center (1) · Southwest Hospital, China (1) · University of Helsinki (1) · University of South Florida (1) · Yale University (1)
United States (7) · United Kingdom (2) · Canada (1) · Finland (1) · Germany (1) · Hungary (1) · Kenya (1) · Netherlands (1) · Norway (1)
Abhishek Abhishek (2) · Angeles Lopez-Olivo (1) · John D. Carter, MD (1) · Marjatta Leirisalo-Repo, MD (1) · Monique Hinchcliff, MD (1) · Ramiro Gutierrez, MD (1) · Wanzhu Hou, CMD (1)
PMID 19248087, PMID 20155838, PMID 20498207, PMID 21622969, PMID 21885496, PMID 22168993, PMID 33207794, PMID 42663270
K08CA237619 (1), R21AR053646 (1)